Briacell Therapeutics Corp Cash Flow-to-Debt Ratio
Briacell Therapeutics Corp cash flow-to-debt ratio. Briacell Therapeutics Corp (BCTX) has a Cash Flow-to-Debt Ratio of -1.93x as of April 2026, meaning its operating cash flow of $-7.08 Million could theoretically repay -2% of its total liabilities ($3.66 Million) in one year. Check Briacell Therapeutics Corp (BCTX) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Briacell Therapeutics Corp (2006–2025)
Cash flow-to-debt ratio of Briacell Therapeutics Corp from 2006 to 2025. Historical debt coverage capacity for Briacell Therapeutics Corp across 20 annual periods. Check total reinvestment intensity of Briacell Therapeutics Corp to assess the company's total reinvestment commitment from operating cash flow.
Briacell Therapeutics Corp Cash Flow-to-Debt Ratio by Year (2006–2025)
Briacell Therapeutics Corp cash flow-to-debt ratio by year from 2006 to 2025. Year-by-year debt coverage analysis for Briacell Therapeutics Corp. For the full cash flow conversion analysis, see Briacell Therapeutics Corp (BCTX) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.59x | $-39.07 Million | $5.93 Million | ▼ -137.3% |
| 2024 | -2.78x | $-32.97 Million | $11.88 Million | ▼ -259.6% |
| 2023 | -0.77x | $-31.89 Million | $41.32 Million | ▼ -101.1% |
| 2022 | -0.38x | $-15.87 Million | $41.36 Million | ▼ -47.4% |
| 2021 | -0.26x | $-9.89 Million | $37.96 Million | ▲ +31.0% |
| 2020 | -0.38x | $-1.55 Million | $4.12 Million | ▲ +91.6% |
| 2019 | -4.52x | $-5.12 Million | $1.13 Million | ▼ -22.2% |
| 2018 | -3.70x | $-4.95 Million | $1.34 Million | ▼ -71.3% |
| 2017 | -2.16x | $-1.91 Million | $885.90K | ▲ +93.4% |
| 2016 | -32.48x | $-1.58 Million | $48.59K | ▼ -220.7% |
| 2015 | -10.13x | $-1.19 Million | $117.17K | ▲ +36.2% |
| 2014 | -15.87x | $-397.42K | $25.04K | ▼ -209.6% |
| 2013 | -5.13x | $-381.80K | $74.46K | ▼ -280.4% |
| 2012 | -1.35x | $-382.74K | $283.94K | ▼ -47.1% |
| 2011 | -0.92x | $-656.68K | $716.66K | ▲ +91.6% |
| 2010 | -10.93x | $-318.63K | $29.15K | ▼ -364.5% |
| 2009 | -2.35x | $-151.05K | $64.19K | ▲ +59.0% |
| 2008 | -5.73x | $-89.68K | $15.64K | ▲ +37.4% |
| 2007 | -9.16x | $-87.76K | $9.58K | ▼ -13544.3% |
| 2006 | 0.07x | $1.13K | $16.54K | — |